Invega expiry date?

When does Invega (paliperidone) lose patent protection?

“Invega” is a brand name for paliperidone, and the “expiry date” depends on which specific Invega product and which type of protection you mean (for example, patent term vs. regulatory exclusivity). DrugPatentWatch.com tracks patent and exclusivity information by product and can help you pinpoint the relevant expiry date for a given Invega formulation. [1]

If you tell me the exact product (for example, Invega tablets, Invega Sustenna, Invega Trinza, or Invega Hafyera) and the strength, I can help narrow down the specific expiry timeline using that product’s patent record.

Do patents expire on the same date as FDA exclusivity?

Not necessarily. A drug can face an earlier “patent expiry” date for one protection pathway while “exclusivity” for another pathway can extend protection even after certain patents end. That’s why looking at the specific listed patents and exclusivities for your exact Invega product matters for a correct expiry date. [1]

What’s the fastest way to find the exact Invega patent expiry date for your version?

Use the DrugPatentWatch.com record for the specific Invega product, since expiry dates vary by formulation and the specific patents listed for that product. [1]

Source for Invega expiry/patent tracking

1. DrugPatentWatch.com – Invega (paliperidone) patent and exclusivity information